Cardiac Concepts, located in Minnetonka, MN, is a leading company specializing in innovative technologies for the treatment of Central Sleep Apnea (CSA) in adults. Their flagship product, the remed System, is an implantable phrenic nerve stimulator that restores a more normal breathing pattern during sleep, effectively addressing the harmful effects of CSA. With FDA approval and a commitment to patient safety, Cardiac Concepts is dedicated to improving the quality of life and overall health of individuals suffering from this serious breathing disorder.
Founded in 2006 and acquired by ZOLL in 2021, Cardiac Concepts, now a part of ZOLL Respicardia, is at the forefront of advancements in CSA treatment. Their expertise in neurostimulation technology and their focus on clinical research and patient outcomes make them a trusted name in the field. With a mission to provide effective solutions for CSA, Cardiac Concepts is dedicated to helping patients find relief and regain control of their sleep and overall well-being.
Generated from the website